Glucagon-like peptide-1 (GLP-1) compounds have emerged as a compelling therapeutic target for managing metabolic syndromes. These naturally occurring substances are secreted by the gut in response to meal intake, https://socialrus.com/story22090657/unveiling-the-therapeutic-potential-of-glp-1-peptides